Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07050589 · ClinicalTrials.gov registry record · NA
Group Recreation to Enhance Function Aging
A NA study of Cognitive Functioning and Physical Functioning, sponsored by State University of New York at Buffalo.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT07050589: Recruiting NA study of Cognitive Functioning and Physical Functioning, sponsored by State University of New York at Buffalo.
NCT07050589 is a NA study of Cognitive Functioning and Physical Functioning that is actively recruiting participants, run by State University of New York at Buffalo. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07050589, a NA study of Cognitive Functioning and Physical Functioning, is actively recruiting participants, sponsored by State University of New York at Buffalo.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
Investigators will develop and deliver a community-based recreation program, delivering group artmaking and group SMARTfit dual-task exergaming to community-dwelling older adults. The program will be delivered through the Buffalo-Niagara YMCA. Outcomes of interest are change in cognitive function and change in physical functioning, inresponse to 24 weeks of weekly training.
Primary Outcome
Change in performance on the Trail-Making Test
Conditions Studied
Interventions
- BEHAVIORAL Exercise and art
Study Locations (1)
New York
- Buffalo-Niagara YMCA - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2025-09-15 |
| Est. Completion | 2026-07-15 |
| Phase | NA |
What NCT07050589 shows while recruiting
NCT07050589 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Cognitive Functioning appearing as the primary indexed condition, and to 1 intervention - of which Exercise and art is the first listed.
NCT07050589 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07050589 about?
NCT07050589 is a clinical study titled "Group Recreation to Enhance Function Aging". Investigators will develop and deliver a community-based recreation program, delivering group artmaking and group SMARTfit dual-task exergaming to community-dwelling older adults. The program will be delivered through the Buffalo-Niagara YMCA. Outcomes of interest are change in cognitive function an...
What is the current status of trial NCT07050589?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2025-09-15. Estimated completion is 2026-07-15.
What conditions does trial NCT07050589 study?
This clinical trial studies the following conditions: Cognitive Functioning, Physical Functioning.
What interventions are being tested in trial NCT07050589?
The interventions under investigation include: Exercise and art (BEHAVIORAL).
Who is sponsoring clinical trial NCT07050589?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07050589 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cognitive Functioning
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07050589's enrollment target sits among peer trials
80 994th of 2000 higher than 941 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI